NRB Inc. (KOSDAQ:475230)
South Korea · Delayed Price · Currency is KRW
16,280
+990 (6.47%)
Aug 8, 2025, 3:30 PM KST
Checkpoint Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 |
---|
Aug '25 Aug 7, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
---|
| 1.83 | 1.57 | 2.55 | -5.02 |
| 3.33 | 2.63 | 3.03 | 18.66 |
| - | 0.40 | 0.50 | - |
| - | 9.07 | 5.03 | - |
| 0.11 | 0.07 | 0.37 | 0.35 |
| 0.21 | 0.19 | 0.55 | 0.75 |
| - | 6.10% | 24.65% | - |
| - | 2.95% | 7.40% | - |
| - | 4.00% | 10.31% | - |
Return on Capital Employed (ROCE) | 5.90% | 10.00% | 15.30% | 4.80% |
| - | -43.49% | -702.71% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.